Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 3Phase 3 1

Status

Completed 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 15INDUSTRY 4OTHER_GOV 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Non-Small-Cell Lung 685Breast Neoplasms 584Neoplasms 468Colorectal Neoplasms 298Prostatic Neoplasms 262Neoplasm Metastasis 256Melanoma 241Ovarian Neoplasms 228Recurrence 216Lung Neoplasms 203Multiple Myeloma 195Lymphoma, Non-Hodgkin 155Pancreatic Neoplasms 154Leukemia, Myeloid, Acute 141Carcinoma, Hepatocellular 141Stomach Neoplasms 137Lymphoma 131Carcinoma, Renal Cell 128Glioblastoma 118Head and Neck Neoplasms 112Squamous Cell Carcinoma of Head and Neck 111Lymphoma, Follicular 106Leukemia, Lymphocytic, Chronic, B-Cell 99Lymphoma, Large B-Cell, Diffuse 96Leukemia 96Small Cell Lung Carcinoma 95Brain Neoplasms 91Carcinoma 82Uterine Cervical Neoplasms 76Triple Negative Breast Neoplasms 72

Interventions

plocabulin 1N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Advanced Colorectal Cancer × Clear all
NCT06838546 2025-02-20

A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer

Tasly Biopharmaceuticals Co., Ltd.

Phase 2 Not yet recruiting
80 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT03427268 2021-05-24

Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment

PharmaMar

Phase 2 Completed
32 enrolled 22 charts
Gastrointestinal

Advanced Colorectal Cancer

NCT00309179 2017-09-14

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Eisai Inc.

Phase 2 Completed
41 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT00824161 2012-04-23

Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer

Taiho Pharmaceutical Co., Ltd.

Phase 2 Terminated
28 enrolled 8 charts
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡